Research Journal of Pharmacy and Technology
SCOPUS
  • Year: 2022
  • Volume: 15
  • Issue: 3

In silico study of natural inhibitors for human papillomavirus-18 E6 protein

  • Author:
  • Annise Proboningrat1, Viol Dhea Kharisma2, Arif Nur Muhammad Ansori1, Rinza Rahmawati3, Amaq Fadholly1, Gabrielle Ann Villar Posa4, Sri Agus Sudjarwo5, Fedik Abdul Rantam6,7, Agung Budianto Achmad8,*
  • Total Page Count: 6
  • Page Number: 1251 to 1256

1Doctoral Program in Veterinary Science, Faculty of Veterinary Medicine, Universitas Airlangga, 60115, Surabaya, Indonesia

2Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Brawijaya, 65145, Malang, Indonesia

3Department of Chemistry, Faculty of Health Sciences, Muhammadiyah University of Surabaya, 60113, Surabaya, Indonesia

4School of Environmental Science and Management, University of the Philippines Los Banos, Los Banos, Philippines

5Department of Pharmacology, Faculty of Veterinary Medicine, Universitas Airlangga, 60115, Surabaya, Indonesia

6Department of Microbiology, Faculty of Veterinary Medicine, Universitas Airlangga, 60115, Surabaya, Indonesia

7Research Center for Vaccine Technology and Development, Institute of Tropical Disease, Universitas Airlangga, 60115, Surabaya, Indonesia

8Department of Health, Faculty of Vocational Studies, Universitas Airlangga, 60115, Surabaya, Indonesia

*Corresponding Author E-mail: ab.achmad@vokasi.unair.ac.id

Online published on 14 June, 2022.

Abstract

Globally, the leading cause of death from cancer in women is infection with the human papillomavirus (HPV). This calls for imperative actions to explore anticancer drugs against this threatening viral infection, in which case, natural ingredients are presumed to be a promising source. Several studies show that plant-origin compounds such as allicin, apigenin, capsaicin, cyanidin, fisetin, genistein, laricitrin, naringenin, piperine, and syringetin have demonstrated therapeutic effects against several cancer types. In this study, the interaction mechanism of these compounds with HPV-18 E6 oncoprotein, that is known to downregulate tumor suppressor p53, was predicted using an in silico approach. Molecular docking simulations of natural ligands and E6 protein were performe, followed by chemical interaction analysis and 3D molecular visualization. Results indicated that fisetin is the best natural inhibitor as it has the lowest binding energy. It is highly recommended that the results of this study be used as a reference in designing anticancer drugs in vitro and in vivo.

Keywords

HPV, E6, Cervical cancer, Inhibitors, Virtual screening